Skip to main content
Erschienen in: Current Infectious Disease Reports 2/2012

01.04.2012 | Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Topical Treatment of Chronic Suppurative Otitis Media

verfasst von: Sam J. Daniel

Erschienen in: Current Infectious Disease Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Chronic suppurative otitis media (CSOM) is a chronic inflammation of the middle ear and mastoid cavity presenting with ear discharge or otorrhea through a non-intact tympanic membrane. CSOM is the most common cause of childhood hearing impairment in developing countries. Accurate diagnosis depends on a high index of suspicion, micro-otoscopic examination, and judicious use of imaging as required. CSOM can be classified into 3 types: tubotympanic, atticoantral, and post-tympanostomy tube insertion. Aerobes, anaerobes and fungi are all potential pathogens in CSOM. This review summarizes the results of recent studies on the bacteriology of CSOM, biofilms, and the role of the nasopharynx pathogens that may have important implications for the treatment of this important pathology; that is often associated with misdiagnosis or delayed diagnosis. Particular emphasis will be placed on topical treatment options including choices of antibiotic, antifungal, and antiseptic agents, delivery technique, spectrum of activity, and risk of ototoxicity.
Literatur
1.
Zurück zum Zitat Daniel SJ, Kozak FK, Fabian MC, et al. Guidelines for the treatment of tympanostomy tube otorrhea. J Otolaryngol. 2005;34 Suppl 2:S60–3.PubMed Daniel SJ, Kozak FK, Fabian MC, et al. Guidelines for the treatment of tympanostomy tube otorrhea. J Otolaryngol. 2005;34 Suppl 2:S60–3.PubMed
2.
Zurück zum Zitat Roland PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J. 2002;81(8 Suppl 1):8–10.PubMed Roland PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J. 2002;81(8 Suppl 1):8–10.PubMed
3.
Zurück zum Zitat Goycoolea MV, Hueb MM, Ruah C. Otitis media: the pathogenesis approach. Definitions and terminology. Otolaryngol Clin North Am. 1991;24(4):757–61.PubMed Goycoolea MV, Hueb MM, Ruah C. Otitis media: the pathogenesis approach. Definitions and terminology. Otolaryngol Clin North Am. 1991;24(4):757–61.PubMed
4.
Zurück zum Zitat •• Madana J, Yolmo D, Kalaiarasi R, et al. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Int J Pediatr Otorhinolaryngol. 2011;75(9):1104–8. This study showed that in attico-antral CSOM with cholesteatoma, the most common organisms was P. aeruginosa, P. mirabilis and S. aureus; all were susceptibie to ceftazidime and vancomycin.PubMedCrossRef •• Madana J, Yolmo D, Kalaiarasi R, et al. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Int J Pediatr Otorhinolaryngol. 2011;75(9):1104–8. This study showed that in attico-antral CSOM with cholesteatoma, the most common organisms was P. aeruginosa, P. mirabilis and S. aureus; all were susceptibie to ceftazidime and vancomycin.PubMedCrossRef
5.
Zurück zum Zitat Bowd AD. Otitis media: health and social consequences for aboriginal youth in Canada’s north. Int J Circumpolar Health. 2005;64(1):5–15.PubMed Bowd AD. Otitis media: health and social consequences for aboriginal youth in Canada’s north. Int J Circumpolar Health. 2005;64(1):5–15.PubMed
6.
Zurück zum Zitat Daly KA, Hunter LL, Giebink GS. Chronic otitis media with effusion. Pediatrics in review/American Academy of Pediatrics. 1999;20(3):85–93. quiz 94.PubMedCrossRef Daly KA, Hunter LL, Giebink GS. Chronic otitis media with effusion. Pediatrics in review/American Academy of Pediatrics. 1999;20(3):85–93. quiz 94.PubMedCrossRef
7.
Zurück zum Zitat •• Mathew R, Asimacopoulos E, Valentine P. Toward safer practice in otology: A report on 15 years of clinical negligence claims. Laryngoscope. 2011;121(10):2214–9. This is the first study to report outcomes of negligence claims in otology. Claims in otology are associated with a high success rate. A significant proportion of claims are not related to surgery.PubMedCrossRef •• Mathew R, Asimacopoulos E, Valentine P. Toward safer practice in otology: A report on 15 years of clinical negligence claims. Laryngoscope. 2011;121(10):2214–9. This is the first study to report outcomes of negligence claims in otology. Claims in otology are associated with a high success rate. A significant proportion of claims are not related to surgery.PubMedCrossRef
8.
Zurück zum Zitat Kaplan GJ, Fleshman JK, Bender TR, et al. Long-term effects of otitis media: a ten-year cohort study of Alaskan Eskimo children. Pediatrics. 1973;52(4):577–85.PubMed Kaplan GJ, Fleshman JK, Bender TR, et al. Long-term effects of otitis media: a ten-year cohort study of Alaskan Eskimo children. Pediatrics. 1973;52(4):577–85.PubMed
9.
Zurück zum Zitat Adoga AA, Bakari A, Afolabi OA, et al. Bacterial isolates in chronic suppurative otitis media: a changing pattern? Nigerian journal of medicine: journal of the National Association of Resident Doctors of Nigeria. 2011;20(1):96–8. Adoga AA, Bakari A, Afolabi OA, et al. Bacterial isolates in chronic suppurative otitis media: a changing pattern? Nigerian journal of medicine: journal of the National Association of Resident Doctors of Nigeria. 2011;20(1):96–8.
10.
Zurück zum Zitat Lee SK, Lee MS, Jung SY, et al. Antimicrobial resistance of Pseudomonas aeruginosa from otorrhea of chronic suppurative otitis media patients. Otolaryngol Head Neck Surg. 2010;143(4):500–5.PubMedCrossRef Lee SK, Lee MS, Jung SY, et al. Antimicrobial resistance of Pseudomonas aeruginosa from otorrhea of chronic suppurative otitis media patients. Otolaryngol Head Neck Surg. 2010;143(4):500–5.PubMedCrossRef
11.
Zurück zum Zitat •• Brook I. The role of anaerobic bacteria in chronic suppurative otitis media in children: implications for medical therapy. Anaerobe. 2008;14(6):297–300. This article describes the microbiology, diagnosis and medical management of chronic suppurative otitis media (CSOM) in children highlighting the role of anaerobic bacteria.PubMedCrossRef •• Brook I. The role of anaerobic bacteria in chronic suppurative otitis media in children: implications for medical therapy. Anaerobe. 2008;14(6):297–300. This article describes the microbiology, diagnosis and medical management of chronic suppurative otitis media (CSOM) in children highlighting the role of anaerobic bacteria.PubMedCrossRef
12.
Zurück zum Zitat Brook I. The role of anaerobic bacteria in otitis media: microbiology, pathogenesis, and implications on therapy. Am J Otolaryngol. 1987;8(2):109–17.PubMedCrossRef Brook I. The role of anaerobic bacteria in otitis media: microbiology, pathogenesis, and implications on therapy. Am J Otolaryngol. 1987;8(2):109–17.PubMedCrossRef
13.
Zurück zum Zitat Brook I, Burke P. The management of acute, serous and chronic otitis media: the role of anaerobic bacteria. J Hosp Infect. 1992;22(Suppl A):75–87.PubMedCrossRef Brook I, Burke P. The management of acute, serous and chronic otitis media: the role of anaerobic bacteria. J Hosp Infect. 1992;22(Suppl A):75–87.PubMedCrossRef
14.
Zurück zum Zitat •• Brook I, Yocum P, Shah K. Aerobic and Anaerobic Bacteriology of Otorrhea Associated with Tympanostomy Tubes in Children. Acta Otolaryngol (Stockh). 1998;118:206–10. This article reveals that specimens collected from the external auditory canals can be misleading. Reliable information can be obtained from the ear exudates when collected through the tympanostomy tubes or through the open perforation after their removal.CrossRef •• Brook I, Yocum P, Shah K. Aerobic and Anaerobic Bacteriology of Otorrhea Associated with Tympanostomy Tubes in Children. Acta Otolaryngol (Stockh). 1998;118:206–10. This article reveals that specimens collected from the external auditory canals can be misleading. Reliable information can be obtained from the ear exudates when collected through the tympanostomy tubes or through the open perforation after their removal.CrossRef
15.
Zurück zum Zitat •• Saunders J, Murray M, Alleman A. Biofilms in chronic suppurative otitis media and cholesteatoma: scanning electron microscopy findings. Am J Otolaryngol. 2011;32(1):32–7. Using scanning electron microscopy, this study showed that bacterial biofilms are common in chronic infections associated with cholesteatoma and are present in some cases of chronic suppurative otitis media without cholesteatoma.PubMedCrossRef •• Saunders J, Murray M, Alleman A. Biofilms in chronic suppurative otitis media and cholesteatoma: scanning electron microscopy findings. Am J Otolaryngol. 2011;32(1):32–7. Using scanning electron microscopy, this study showed that bacterial biofilms are common in chronic infections associated with cholesteatoma and are present in some cases of chronic suppurative otitis media without cholesteatoma.PubMedCrossRef
16.
Zurück zum Zitat • Chang J, Lee SH, Choi J, et al. Nasopharynx as a microbiologic reservoir in chronic suppurative otitis media: preliminary study. Clinical and experimental otorhinolaryngology. 2011;4(3):122–5. This study suggests that it is necessary to perform nasopharynx cultures together with conventional middle ear culture to orient antibiotherapy pre-operatively.PubMedCrossRef • Chang J, Lee SH, Choi J, et al. Nasopharynx as a microbiologic reservoir in chronic suppurative otitis media: preliminary study. Clinical and experimental otorhinolaryngology. 2011;4(3):122–5. This study suggests that it is necessary to perform nasopharynx cultures together with conventional middle ear culture to orient antibiotherapy pre-operatively.PubMedCrossRef
17.
Zurück zum Zitat Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: a controlled study. J Laryngol Otol. 1988;102(6):491–5.PubMedCrossRef Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: a controlled study. J Laryngol Otol. 1988;102(6):491–5.PubMedCrossRef
18.
Zurück zum Zitat Saunders MW, Robinson PJ. How easily do topical antibiotics pass through tympanostomy tubes?–an in vitro study. Int J Pediatr Otorhinolaryngol. 1999;50(1):45–50.PubMedCrossRef Saunders MW, Robinson PJ. How easily do topical antibiotics pass through tympanostomy tubes?–an in vitro study. Int J Pediatr Otorhinolaryngol. 1999;50(1):45–50.PubMedCrossRef
19.
Zurück zum Zitat Boyd NH, Gottschall JA. Assessing the efficacy of tragal pumping: a randomized controlled trial. Otolaryngol Head Neck Surg. 2011;144(6):891–3. Epub 2011 Feb 18.PubMedCrossRef Boyd NH, Gottschall JA. Assessing the efficacy of tragal pumping: a randomized controlled trial. Otolaryngol Head Neck Surg. 2011;144(6):891–3. Epub 2011 Feb 18.PubMedCrossRef
20.
Zurück zum Zitat Hannley MT, Denneny 3rd JC, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000;122(6):934–40.PubMedCrossRef Hannley MT, Denneny 3rd JC, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000;122(6):934–40.PubMedCrossRef
21.
Zurück zum Zitat ••Macfadyen CA, Acuin JM, Gamble C: Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane database of systematic reviews 2006(1):CD005608 (online 2009). This study shows that short courses of topical quinolone antibiotics are more effective than systemic antibiotics alone for the short-term resolution of otorrhea from uncomplicated CSOM. ••Macfadyen CA, Acuin JM, Gamble C: Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane database of systematic reviews 2006(1):CD005608 (online 2009). This study shows that short courses of topical quinolone antibiotics are more effective than systemic antibiotics alone for the short-term resolution of otorrhea from uncomplicated CSOM.
22.
Zurück zum Zitat ••Macfadyen CA, Acuin JM, Gamble C: Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations. Cochrane database of systematic reviews 2005(4):CD004618 (online 2009). In this review, short courses of topical quinolone antibiotics were shown to be more effective than no drug treatment or topical antiseptics for the short-term resolution of otorrhea from uncomplicated CSOM. ••Macfadyen CA, Acuin JM, Gamble C: Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations. Cochrane database of systematic reviews 2005(4):CD004618 (online 2009). In this review, short courses of topical quinolone antibiotics were shown to be more effective than no drug treatment or topical antiseptics for the short-term resolution of otorrhea from uncomplicated CSOM.
23.
Zurück zum Zitat Klein JO. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections. Am J Manag Care. 2002;8(14 Suppl):S345–52.PubMed Klein JO. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections. Am J Manag Care. 2002;8(14 Suppl):S345–52.PubMed
24.
Zurück zum Zitat Weber PC, Roland PS, Hannley M, et al. The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S89–94.PubMedCrossRef Weber PC, Roland PS, Hannley M, et al. The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S89–94.PubMedCrossRef
25.
Zurück zum Zitat Agro AS, Garner ET, Wright 3rd JW, et al. Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media. Clin Ther. 1998;20(4):744–59.PubMedCrossRef Agro AS, Garner ET, Wright 3rd JW, et al. Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media. Clin Ther. 1998;20(4):744–59.PubMedCrossRef
26.
Zurück zum Zitat Manolidis S, Friedman R, Hannley M, et al. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S83–8.PubMedCrossRef Manolidis S, Friedman R, Hannley M, et al. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S83–8.PubMedCrossRef
27.
Zurück zum Zitat Macfadyen C, Gamble C, Garner P, et al. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Trop Med Int Health. 2005;10(2):190–7.PubMedCrossRef Macfadyen C, Gamble C, Garner P, et al. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Trop Med Int Health. 2005;10(2):190–7.PubMedCrossRef
28.
Zurück zum Zitat Leach AJ, Morris PS: Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane database of systematic reviews (Online) 2006(4):CD004401. Leach AJ, Morris PS: Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane database of systematic reviews (Online) 2006(4):CD004401.
29.
Zurück zum Zitat Daniel SJ, Munguia R. Ototoxicity of topical ciprofloxacin/dexamethasone otic suspension in a chinchilla animal model. Otolaryngol Head Neck Surg. 2008;139(6):840–5.PubMedCrossRef Daniel SJ, Munguia R. Ototoxicity of topical ciprofloxacin/dexamethasone otic suspension in a chinchilla animal model. Otolaryngol Head Neck Surg. 2008;139(6):840–5.PubMedCrossRef
30.
Zurück zum Zitat Roland PS, Stewart MG, Hannley M, et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S51–6.PubMedCrossRef Roland PS, Stewart MG, Hannley M, et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S51–6.PubMedCrossRef
31.
Zurück zum Zitat Matz G, Rybak L, Roland PS, et al. Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S79–82.PubMedCrossRef Matz G, Rybak L, Roland PS, et al. Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S79–82.PubMedCrossRef
32.
Zurück zum Zitat Ichibangase T, Yamano T, Miyagi M, et al. Ototoxicity of Povidone-Iodine applied to the middle ear cavity of guinea pigs. Int J Pediatr Otorhinolaryngol. 2011;75(9):1078–81.PubMedCrossRef Ichibangase T, Yamano T, Miyagi M, et al. Ototoxicity of Povidone-Iodine applied to the middle ear cavity of guinea pigs. Int J Pediatr Otorhinolaryngol. 2011;75(9):1078–81.PubMedCrossRef
33.
Zurück zum Zitat Boudewyns A, Claes J. Acute cochleovestibular toxicity due to topical application of potassium iodide. Eur Arch Otorhinolaryngol. 2001;258(3):109–11.PubMedCrossRef Boudewyns A, Claes J. Acute cochleovestibular toxicity due to topical application of potassium iodide. Eur Arch Otorhinolaryngol. 2001;258(3):109–11.PubMedCrossRef
34.
Zurück zum Zitat Oishi N, Inoue Y, Saito H, et al. Burow’s solution-induced acute sensorineural hearing loss: report of two cases. Auris Nasus Larynx. 2010;37(3):369–72.PubMedCrossRef Oishi N, Inoue Y, Saito H, et al. Burow’s solution-induced acute sensorineural hearing loss: report of two cases. Auris Nasus Larynx. 2010;37(3):369–72.PubMedCrossRef
35.
Zurück zum Zitat Haynes DS, Rutka J, Hawke M, et al. Ototoxicity of ototopical drops–an update. Otolaryngol Clin North Am. 2007;40(3):669–83. xi. Review.PubMedCrossRef Haynes DS, Rutka J, Hawke M, et al. Ototoxicity of ototopical drops–an update. Otolaryngol Clin North Am. 2007;40(3):669–83. xi. Review.PubMedCrossRef
36.
Zurück zum Zitat Daniel SJ, Akinpelu OV, Sahmkow S, et al. Oxymetazoline ototoxicity in a chinchilla animal model. Otolaryngol Head Neck Surg. 2012;146(1):114–8.PubMedCrossRef Daniel SJ, Akinpelu OV, Sahmkow S, et al. Oxymetazoline ototoxicity in a chinchilla animal model. Otolaryngol Head Neck Surg. 2012;146(1):114–8.PubMedCrossRef
37.
Zurück zum Zitat Isaacson G, Buttaro BA, Mazeffa V, et al. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic. Ann Otol Rhinol Laryngol. 2005;114(8):645–51.PubMed Isaacson G, Buttaro BA, Mazeffa V, et al. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic. Ann Otol Rhinol Laryngol. 2005;114(8):645–51.PubMed
38.
Zurück zum Zitat •• Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72(4):453–9. This review discusses the topical antifungals most commonly used in otomycosis and their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.PubMedCrossRef •• Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72(4):453–9. This review discusses the topical antifungals most commonly used in otomycosis and their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.PubMedCrossRef
39.
Zurück zum Zitat • Daniel SJ, Sahmkow S, Akinpelu OV. Is Ototopical Nystatin Ototoxic?: A Chinchilla Model. Otolaryngol Head Neck Surg. 2011;145(6):1022–4. This study demonstrates the safety of topical nystatin in an animal model.PubMedCrossRef • Daniel SJ, Sahmkow S, Akinpelu OV. Is Ototopical Nystatin Ototoxic?: A Chinchilla Model. Otolaryngol Head Neck Surg. 2011;145(6):1022–4. This study demonstrates the safety of topical nystatin in an animal model.PubMedCrossRef
Metadaten
Titel
Topical Treatment of Chronic Suppurative Otitis Media
verfasst von
Sam J. Daniel
Publikationsdatum
01.04.2012
Verlag
Current Science Inc.
Erschienen in
Current Infectious Disease Reports / Ausgabe 2/2012
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-012-0246-8

Weitere Artikel der Ausgabe 2/2012

Current Infectious Disease Reports 2/2012 Zur Ausgabe

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

The Role of Helicobacter pylori in Upper Respiratory System Infections: Is it More Than Colonization?

Sexually Transmitted Diseases (L Bachmann, Section Editor)

The Promise of Antiretrovirals for HIV Prevention

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Effects of Active and Passive Smoking on Ear Infections

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Dacryocystitis: Systematic Approach to Diagnosis and Therapy

Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Leukotriene Inhibitors in Sinusitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.